Malmström and colleagues 7 collected individual patient data from previous trials of BCG versus mitomycin C and performed a meta-analysis on 2,820 such data sets. After a median follow-up of 4.4 ...

ImmunityBio (IBRX) faces operational, financial, and competitive challenges, impacting its growth prospects despite Anktiva's ...

SESAUA annual meeting featured a bladder cancer session and a presentation by Dr. Meredith Bernhard discussing the oncologic efficacy of reduced versus standard-dose BCG for non muscle invasive ...

In examining why banks struggle to adapt, Nasdaq and BCG found that institutions have ... risk management, oversight, analysis, and innovation. The report advocates for a fundamental mindset ...

The authorization was granted to ImmunityBio, the manufacturer of Anktiva ® (nogapendekin alfa inbakicept-pmln), an interleukin-15 receptor agonist, indicated with BCG for adult patients with BCG ...

GenAI could be India’s next trillion-dollar opportunity, transforming IT services the way cloud computing once did. But India ...

BCG and Bain grew 53% in China between 2017 and 2023, among the highest of any region, according to an analysis published ...

First, it can quickly analyse large amounts of spending data to identify cost-saving opportunities. BCG’s research shows that companies seeing the most success in cost excellence are those that ...

India's retail market is expected to reach INR 190 trillion by 2034, driven by consumption growth. The market will see ...